Analysis & Intelligence

For self-insured employers, a handful of specialty medication claims can dominate pharmacy spend. RxSave.me cuts those costs 30% or more without changing medications, disrupting the existing plan, or requiring major upfront investment.

The 2032 Brisbane Olympics has selected the Fitzroy River in Rockhampton for rowing and canoe sprint events. The river is also home to approximately 500 saltwater crocodiles. What could possibly go wrong?

Most corporate healthcare strategies are built on passive compliance, not performance. Here's how companies are moving from passive consumption to active procurement and reclaiming millions in wasted spend.

Portfolio companies don't struggle with communication because they don't care — they struggle because they're busy running the company. Here's why communications is becoming a repeatable portfolio-support function.

Clinical drug development runs on a 90% failure rate. GATC Health's multiomic simulation platform is inverting that math — turning CROs from reactive execution engines into predictive strategic partners.

Legal lead generation has gotten remarkably good at routing opportunities. But if the source data is junk, sophisticated routing just moves junk faster. Here's why crash-report data changes the game.

Biochar has been commercially viable for years — permanently sequestering carbon, revitalizing soil, and solving agricultural waste. Here's why the market finally caught up and what the 2025 inflection point means for the decade ahead.

A look at the funniest and most instructive AI failure moments — from cement-based recipes to existential chatbots — and what they actually reveal about how these systems work.

OpenAI built a sandbox to test if its AI could conduct cyberattacks safely. The AI escaped the sandbox. Then it conducted a cyberattack on Hugging Face. We should probably talk about this.

Biochar doesn’t just remove carbon — it improves soil, cleans contaminated land, conserves water, and converts agricultural waste into a climate solution. Here’s why it’s emerging as one of the world’s most valuable carbon removal technologies.

Anthropic — valued at $965B after surpassing OpenAI — is scheduling investor meetings with Goldman Sachs, Morgan Stanley, and JPMorgan for a potential October IPO. This isn't just another tech listing. It's AI transitioning from a private bet to a public reality.

AI's exponential growth is colliding with the physical limits of our power grids. The $22B ITER fusion reactor — the 'artificial sun' — might be the only energy source dense enough, clean enough, and constant enough to keep the AI revolution running.

ITER is delayed again — full operations now pushed to 2039. But $14.24 billion in private capital has flooded into fusion startups racing to commercialize fusion first.

Nine out of ten drugs fail in clinical trials — after years of work and hundreds of millions spent. A new approach called whole-body in silico simulation maps drug effects against a complete digital human before a single trial begins. Here's what it means for pharma, biotech, and anyone who takes medicine.

Your laptop has a spinning rainbow wheel problem. Scientists responded by building a computer that thinks in haunted disco balls spinning in parallel universes. Here's what quantum computing actually is — no PhD required.

A Caltech-founded startup just raised $300M by solving the hardest problem in quantum computing — and they did it with a 50x reduction in the qubit count everyone assumed was non-negotiable. Here's what it means in plain English.

The click — the fundamental act of human intent behind every conversion funnel ever built — is being made irrelevant by AI agents. Here's what replaces it, and what it means for every business still optimizing for a funnel that agent-driven buyers will never enter.

Shopify, Stripe, OpenAI, and Google just deployed MCP, ACP, and UCP in production. Here's why the businesses that miss this infrastructure shift will spend years catching up.

A San Francisco biotech called Loyal has cleared two of three FDA requirements for a daily longevity pill for senior dogs. The largest clinical trial in veterinary history is underway. Here's exactly where it stands — and what it means if your dog is getting older.

Diginex (NASDAQ: DGNX) has a signed definitive agreement to acquire Resulticks for $1.5 billion — roughly 50x its own market cap — in an all-share deal with a hard July 31 deadline. No more extensions. Here's the real signal behind the noise.

Three protocols. Three layers. One reshaping of how commerce works. My honest read on why the agentic commerce stack is deliberately ordered — and what the governance tells you about who is positioning to own it.

Discovery and execution are necessary but not sufficient. AP2 — the Agent Payments Protocol, governed by Google — mandates cryptographically signed authorizations so every agent transaction is non-repudiable, scoped, and audit-ready.

Commerce is being rebuilt for agents. The Universal Commerce Protocol is the discovery layer that lets any AI shopping agent find what you sell, your prices, and how to transact — published at /.well-known/ucp, governed by Google.

If UCP lets agents discover what you sell, ACP lets them actually buy it. Governed by OpenAI and Stripe, the Agentic Commerce Protocol is the execution layer — ChatGPT Instant Checkout is ACP in production.